Letter to the Editor Open Access
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Feb 16, 2024; 12(5): 1029-1032
Published online Feb 16, 2024. doi: 10.12998/wjcc.v12.i5.1029
Response letter to “Acute cholangitis: Does malignant biliary obstruction vs choledocholithiasis etiology change the outcomes?” with imaging aspects
Sonay Aydin, Baris Irgul, Department of Radiology, Erzincan Binali Yildirim University, Erzincan 24100, Turkey
ORCID number: Sonay Aydin (0000-0002-3812-6333); Baris Irgul (0000-0002-7551-8686).
Author contributions: Aydin S and Irgul B conceived and designed the analysis, collected the data, wrote the paper and performed the analysis.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Baris Irgul, MD, Research Assistant, Department of Radiology, Erzincan Binali Yildirim University, No. 32 Haci Ali Akin Street, Erzincan 24100, Turkey. barisirgul@gmail.com
Received: October 26, 2023
Peer-review started: October 26, 2023
First decision: December 7, 2023
Revised: December 12, 2023
Accepted: January 24, 2024
Article in press: January 24, 2024
Published online: February 16, 2024
Processing time: 96 Days and 19.8 Hours

Abstract

Radiological imaging findings may contribute to the differentiation of malignant biliary obstruction from choledocholithiasis in the etiology of acute cholangitis.

Key Words: Malignant biliary obstruction; Choledocholithiasis; Acute cholangitis; Dilated bile ducts; Magnetic resonance cholangiopancreatography; Endoscopic retrograde cholangiopancreatography

Core Tip: In malignant biliary obstructions, irregular walls, increased wall thickness, and blunt termination are seen in the choledochal duct. In choledocholithiasis, stones are seen in the lumen and the choledochal walls are regular.



TO THE EDITOR

We were intrigued by the paper “Acute cholangitis: Does malignant biliary obstruction vs choledocholithiasis etiology change the clinical presentation and outcomes?” by Tsou et al[1]. This study primarily examined laboratory data to distinguish between malignant biliary obstruction and obstruction caused by stones and underscored it’s significance. However, the study did not investigate the role and significance of imaging in this differentiation. In this letter to the editor, we aim to highlight the crucial imaging indicators for the aforementioned differentiation.

In the current era of medical imaging, which offers a wide range of imaging techniques from basic radiographs to advanced magnetic resonance imaging (MRI) scans, the role of the radiologist is to assist the physician in choosing the appropriate imaging method and addressing important patient care issues. Ultrasound (US) is used as a preliminary method to screen for biliary obstruction, but it cannot accurately establish the severity and cause of obstructive jaundice. Therefore, further imaging with techniques like contrast enhanced computerized tomography and magnetic resonance cholangiopancreatography (MRCP) are necessary as they are more effective in providing accurate diagnostic information. MRCP has become the preferred method for examining biliary obstruction, with endoscopic retrograde cholangiopancreatography being reserved for patients who are more likely to require therapeutic intervention[2].

The Tokyo Guidelines are employed for the diagnosis of acute cholangitis. According to these criteria, acute cholangitis can be diagnosed based on signs of systemic inflammation, cholestasis, and imaging results[3]. Calculi and dilatation can be observed in the bile ducts on US and computed tomography (CT) scans due to the presence of stones in acute cholangitis caused by choledocholithiasis. MRCP scans reveal signal attenuation caused by the presence of calculi. The bile duct walls exhibit a rather slender and sleek shape[4] (Figure 1).

Figure 1
Figure 1 Choledochal obstruction caused by calculus. A: Fat-suppressed T2 WI shows calculus (white arrows) in the dilated choledochal duct (circle) and bile sludge (orange arrow). The patient also has autosomal dominant polycystic kidney disease (orange arrows); B: HASTE coronal image shows calculus (white arrow) in the dilated choledochal duct (circle) with smooth borders (curved lines); C: Coronal computed tomography image shows a dilated choledochal duct (circle) with calculus (white arrow) P: Pancreas.

Acute cholangitis caused by malignant biliary obstructions is characterized by the enlargement of the biliary tract, which can be detected using US, CT, and MRCP, similar to the presentation in cases of choledocholithiasis. Furthermore, intraductal mass lesions are present, with extensive segments of contrasting bile duct walls that are uneven and thicker (> 1.5 mm). Additionally, blunt terminations in the bile ducts caused by distal tumoral lesions are visible[4] (Figure 2).

Figure 2
Figure 2 Choledochal involvement of a pancreatic mass. A and B: Coronal T2 WI and coronal magnetic resonance cholangiopancreatography images. The dilated choledochal duct (circle) abruptly narrows bluntly (white arrow) and continues narrowly in a long segment more distally (two-headed arrow). Contour irregularities (serrated lines) are seen on the distal walls of the choledochal duct; C and D: Post-treatment axial and coronal computed tomography images of the same patient show an irregularly bordered, hypodense, heterogeneous, solid mass lesion (circle) in the head of the pancreas, stent material extending from the duodenum to the pancreas (orange arrow), and dilated intrahepatic bile ducts (white arrow).

In conclusion, while certain imaging findings have been identified to distinguish between cancer and stone-induced blockages, there is currently no universally accepted approach or finding to definitively differentiate between the two. If a routinely used imaging modality like MRCP reveals any secondary finding that indicates malignant blockage, multiphase-dynamic CT/MRI is recommended for optimal evaluation of nearby organs such as the biliary system and pancreas. In addition, US is sufficient to explain the etiology of biliary obstructions such as stones. When the cause of obstruction cannot be found with US, second- and third-level imaging techniques such as CT, MRI, or endoscopic ultrasonography are needed; however, their unnecessary overuse should be avoided.

Footnotes

Provenance and peer review: Unsolicited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Medicine, research and experimental

Country/Territory of origin: Turkey

Peer-review report’s scientific quality classification

Grade A (Excellent): 0

Grade B (Very good): B

Grade C (Good): C

Grade D (Fair): 0

Grade E (Poor): E

P-Reviewer: Dabbous H, Egypt; Salerno R, Italy; Wen XL, China S-Editor: Qu XL L-Editor: Filipodia P-Editor: Zhao S

References
1.  Tsou YK, Su YT, Lin CH, Liu NJ. Acute cholangitis: Does malignant biliary obstruction vs choledocholithiasis etiology change the clinical presentation and outcomes? World J Clin Cases. 2023;11:6984-6994.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
2.  Joshi A, Rajpal K, Kakadiya K, Bansal A. Role of CT and MRCP in Evaluation of Biliary Tract Obstruction. Curr Radiol Rep. 2014;72:2.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 1]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
3.  Kiriyama S, Kozaka K, Takada T, Strasberg SM, Pitt HA, Gabata T, Hata J, Liau KH, Miura F, Horiguchi A, Liu KH, Su CH, Wada K, Jagannath P, Itoi T, Gouma DJ, Mori Y, Mukai S, Giménez ME, Huang WS, Kim MH, Okamoto K, Belli G, Dervenis C, Chan ACW, Lau WY, Endo I, Gomi H, Yoshida M, Mayumi T, Baron TH, de Santibañes E, Teoh AYB, Hwang TL, Ker CG, Chen MF, Han HS, Yoon YS, Choi IS, Yoon DS, Higuchi R, Kitano S, Inomata M, Deziel DJ, Jonas E, Hirata K, Sumiyama Y, Inui K, Yamamoto M. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25:17-30.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 226]  [Cited by in F6Publishing: 363]  [Article Influence: 60.5]  [Reference Citation Analysis (0)]
4.  Choi SH, Han JK, Lee JM, Lee KH, Kim SH, Lee JY, Choi BI. Differentiating malignant from benign common bile duct stricture with multiphasic helical CT. Radiology. 2005;236:178-183.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 90]  [Cited by in F6Publishing: 81]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]